Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Eargo, Inc.
  6. News
  7. Summary
    EAR   US2700871096


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

EAR CLASS ACTION: Hagens Berman Encourages Eargo (EAR) Investors with +$500k Losses to Contact Firm's Attorneys Now, Application Deadline Approaching in Securities Fraud Lawsuit

11/17/2021 | 09:32am EST

SAN FRANCISCO, Nov. 17, 2021 /PRNewswire/ -- Hagens Berman urges Eargo, Inc. (NASDAQ: EAR) investors with losses in excess of $500,000 to submit your losses now.  

Class Period: Oct. 15, 2020Sept. 22, 2021
Lead Plaintiff Deadline: Dec. 6, 2021
Visit: www.hbsslaw.com/cases/EAR 
Contact An Attorney Now: EAR@hbsslaw.com 

Eargo, Inc. (EAR) Securities Fraud Class Action:

Eargo, a hearing aid manufacturer, targets consumers with hearing aid insurance, and provides insurance claims processing for these customers.  Consequently, a significant portion of Eargo's accounts receivables is insurance reimbursement claims the Company has submitted to government-sponsored healthcare and private insurance.

The complaint alleges that Defendants misled investors between Oct. 15, 2021Sept. 22, 2021 concerning the extent of available insurance coverage for Eargo's products and how that coverage purportedly drove the company's earnings and growth. 

More specifically, according to the complaint, Eargo and senior management failed to disclose that (1) Eargo improperly sought reimbursements from certain third-party payors, (2) the foregoing was reasonably likely to lead to regulatory scrutiny, and (3) as a result and because the reimbursements at issue involved the company's largest third-party payor, Eargo's financial results would be adversely impacted.

The complaint alleges investors began to learn the truth on Aug. 12, 2021, when in reporting its Q2 2021 financial results, Eargo revealed that its largest third-party payor was conducting a claims audit and had not paid Eargo since March 1, 2021.

Then, on Sept. 22, 2021, Eargo announced it is the target of a criminal investigation by the DOJ related to insurance reimbursement claims the company submitted on behalf of customers covered by Federal employee health plans.  The company also announced its withdrawal of increased FY 2021 revenue guidance given to investors during its Aug. 12, 2021 Q2 2021 earnings call.

"We're focused on investors' losses and proving Eargo lied about its compliance with applicable laws and its revenue recognition practices," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Eargo, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Eargo should consider their options to help in the investigation or take advantage of the SEC Whistleblower program.  Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.  For more information, call Reed Kathrein at 844-916-0895 or email EAR@hbsslaw.com.

About Hagens Berman
Hagens Berman is a national law firm with eight offices in eight cities around the country and over eighty attorneys.  The firm represents investors, whistleblowers, workers and consumers in complex litigation.  More about the firm and its successes is located at hbsslaw.com.  For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.

Reed Kathrein, 844-916-0895

View original content to download multimedia:https://www.prnewswire.com/news-releases/ear-class-action-hagens-berman-encourages-eargo-ear-investors-with-500k-losses-to-contact-firms-attorneys-now-application-deadline-approaching-in-securities-fraud-lawsuit-301426295.html

SOURCE Hagens Berman Sobol Shapiro LLP

ę PRNewswire 2021
All news about EARGO, INC.
01/20Eargo Applauds Proposed Rule for OTC Hearing Aids and Submits Public Comments to FDA
01/18EARGO, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits..
01/18Eargo, Inc. Promotes Mark Thorpe to Chief Accounting Officer
01/06Health Care Stocks Ending Near Intra-Day Lows
01/06Eargo Shares Leap as DOJ Criminal Probe No Longer Active
01/06Eargo Says US Justice Department Halted Criminal Probe; Shares Soar
01/06EARGO, INC. : Other Events (form 8-K)
01/05Eargo Launches Eargo 6 Hearing Aid
01/04Eargo Launches Eargo 6 with Sound Adjust for Effortless Hearing
More news
Analyst Recommendations on EARGO, INC.
More recommendations